Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report)'s share price dropped 5.1% during mid-day trading on Wednesday . The company traded as low as $62.12 and last traded at $61.64. Approximately 53,241 shares were traded during trading, a decline of 86% from the average daily volume of 387,956 shares. The stock had previously closed at $64.94.
Semler Scientific Stock Performance
The firm has a market cap of $578.28 million, a price-to-earnings ratio of 30.61 and a beta of 1.18. The business's 50-day moving average is $59.62 and its 200-day moving average is $39.83.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. The firm had revenue of $13.51 million during the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Newbridge Financial Services Group Inc. acquired a new position in Semler Scientific during the second quarter worth $34,000. Quest Partners LLC increased its holdings in Semler Scientific by 48.0% in the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company's stock worth $59,000 after acquiring an additional 817 shares during the last quarter. US Bancorp DE boosted its position in shares of Semler Scientific by 60.8% during the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company's stock valued at $72,000 after acquiring an additional 1,158 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in Semler Scientific in the 3rd quarter worth approximately $104,000. Finally, Rhumbline Advisers raised its holdings in Semler Scientific by 27.1% in the second quarter. Rhumbline Advisers now owns 6,197 shares of the company's stock worth $213,000 after purchasing an additional 1,320 shares in the last quarter. Institutional investors own 49.37% of the company's stock.
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
